Skip to main content
. 2016 Apr 4;23(4):282–293. doi: 10.1128/CVI.00554-15

FIG 1.

FIG 1

Percentages of volunteers whose PBMC showed proliferative responses to individual 20-mer peptides derived from Rv1860 among 28 latently M. tuberculosis-infected healthy volunteers (HV) (A) and 20 TB patients (PAT) (B). The three most immunodominant peptides, 1803, 1821, and 1826, are highlighted in panel A.